Delivery Order SPE2DB22D9367-SPE2DB24FSV41
Award Date
12/14/23
Potential Completion Date
1/8/24
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand two dollars and thirteen cents ($3,002.13) by the Defense Logistics Agency. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide one hundred milliliters of Purixan 20...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,002.13 to supply 100ml of Purixan 20mg/ml oral suspension to the Defense Logistics Agency under an indefinite delivery contract. The contract has no set-aside designation. DMS Pharmaceutical Group will perform as the prime contractor, supplying the pharmaceutical item from its location in Park Ridge, Illinois to the Defense Logistics Agency by December 18, 2023. DMS Pharmaceutical Group holds additional...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $2,123.70, is for the delivery of Purixan 20 mg/ml oral suspension (100 ml) and has a period of performance through May 14, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders for a comprehensive range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued up to $3,852.56, is for the delivery of PURIXAN 20 MG/ML ORAL SUSP 100ML, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which allows the DLA to...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,137.16 order is for Purixan, a 20 mg/mL oral suspension medication, with a completion date of July 16, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, was issued by the Defense Logistics Agency (DLA) on September 10, 2021. The $7,258.24 firm fixed-price delivery order contract is for the pharmaceutical product Purixan 20 mg/ml oral suspension in 100 ml bottles. The contract has an ultimate completion date of October 1, 2021 and is not associated with any set-aside designation. DMS Pharmaceutical Group is a key supplier in the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,331.04 order is for the supply of Purixan, a 20 mg/mL oral suspension medication, with a completion date of October 19, 2021. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999 and running through...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at three thousand eight dollars and one cent ($3,008.01) to DMS Pharmaceutical Group Inc. to supply one hundred (100) milliliters of the oral suspension Purixan at twenty (20) milligrams per milliliter. The place of performance will be DMS Pharmaceutical's facility located at Park Ridge, Illinois. The period of performance is scheduled from September twenty-second, two thousand twenty-three through October sixteenth,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,061.84, is for the delivery of Purixan 20 mg/ml oral suspension in 100 ml containers. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,705.12 firm fixed-price delivery order is for the pharmaceutical product Purixan 20 mg/ml oral suspension, 100 ml, and has a completion date of July 11, 2022. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows...